Literature DB >> 4852211

Haemodynamic effects of ajmaline in man.

H Saetre, G Ahlmark, G Ahlberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4852211     DOI: 10.1007/bf00560340

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  17 in total

1.  [ELECTROPHYSIOLOGICAL STUDIES ON THE EFFECT OF AJMALINE ON CONDUCTION FIBERS].

Authors:  B PILLAT; P HEISTRACHER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-02-13

2.  [EMERGENCY TREATMENT OF CARDIAC RHYTHM DISORDERS WITH INTRAVENOUS AJMALINE].

Authors:  R SLAMA; J P FOUCAULT; Y BOUVRAIN
Journal:  Presse Med       Date:  1963-11-09       Impact factor: 1.228

3.  [ELECTROPHYSIOLOGICAL STUDIES ON THE MECHANISM OF ACTION OF AN ANTIFIBRILLATION AGENT ON THE RATE OF RISE OF THE ACTION POTENTIAL OF PURKINJE FIBERS].

Authors:  P HEISTRACHER
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1964-05-15

4.  [EXPERIENCES WITH THE TREATMENT OF EXTRASYSTOLE].

Authors:  H J LORDICK
Journal:  Dtsch Med J       Date:  1964-10-05

5.  [On the pharmacology of ajmaline].

Authors:  H SCHMITT H SCHMITT
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-08-01

6.  [On the mechanism of action of ajmaline].

Authors:  G KUSCHINSKY; H REUTER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1961

7.  [Behavior of the serum level after intravenous injections of ajmaline].

Authors:  H KLEINSORGE; P GAIDA
Journal:  Klin Wochenschr       Date:  1962-02-01

8.  [On some physiological properties of pure Siddiqui ajmaline].

Authors: 
Journal:  C R Hebd Seances Acad Sci       Date:  1957-12-04

9.  [Contribution to the determination of anti-fibrillary properties of quinidine and substances with similar effect].

Authors:  H F BENTHE
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1956

10.  [Clinical experiences with Ajmaline].

Authors:  H E RENSCHLER; J HAMM
Journal:  Med Welt       Date:  1961-10-28
View more
  3 in total

1.  Anything to declare? Possible risks for patients' health resulting from undeclared plants in herbal supplements.

Authors:  Eugenia Gallo; Elisa Giocaliere; Silvia Benemei; Anna Rita Bilia; Anastasia Karioti; Alessandra Pugi; Marina di Pirro; Francesca Menniti-Ippolito; Giuseppe Pieraccini; Luigi Gori; Alessandro Mugelli; Fabio Firenzuoli; Alfredo Vannacci
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

2.  Kinetics of ajmaline disposition and pharmacologic response in beagle dogs.

Authors:  M Yasuhara; Y Hashimoto; K Okumura; R Hori; T Sakurai; C Kawai
Journal:  J Pharmacokinet Biopharm       Date:  1987-02

3.  Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion.

Authors:  Y Hashimoto; R Hori; K Okumura; M Yasuhara
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.